Role of CaMKII in cardiac arrhythmias

Trends in Cardiovascular Medicine

Volumn 25, Issue 5, 2015, Pages 392-397

  Hund, Thomas J ^a,b,c   Mohler, Peter J ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c The Ohio State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM ION; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; RANOLAZINE; REACTIVE OXYGEN METABOLITE; SODIUM ION;

ANTIARRHYTHMIC ACTIVITY; APOPTOSIS; CARDIOVASCULAR DISEASE; CELL MEMBRANE; CELLULAR DISTRIBUTION; DRUG TARGETING; EPITHELIUM CELL; HEART ARRHYTHMIA; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE EXCITABILITY; HEART MUSCLE POTENTIAL; HUMAN; MATHEMATICAL MODEL; MUSCLE CELL; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; SODIUM CURRENT; ENZYMOLOGY; METABOLISM; MOLECULARLY TARGETED THERAPY; PHYSIOLOGY; THEORETICAL MODEL;

ARRHYTHMIAS, CARDIAC; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; HUMANS; MODELS, THEORETICAL; MOLECULAR TARGETED THERAPY; SIGNAL TRANSDUCTION;

EID: 84930759346     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2014.12.001     Document Type: Review

References (62)

1. Srinivasan M., Edman C.F., Schulman H. Alternative splicing introduces a nuclear localization signal that targets multifunctional CaM kinase to the nucleus. J Cell Biol 1994, 126:839-852.
2. Mishra S., Gray C.B., Miyamoto S., Bers D.M., Brown J.H. Location matters: clarifying the concept of nuclear and cytosolic CaMKII subtypes. Circ Res 2011, 109:1354-1362.
3. Swaminathan P.D., Purohit A., Hund T.J., Anderson M.E. Calmodulin-dependent protein kinase II: linking heart failure and arrhythmias. Circ Res 2012, 110:1661-1677.
4. 2+/calmodulin-dependent kinase II. Mol Cell 2003, 11:1241-1251.
5. Hanson P.I., Meyer T., Stryer L., Schulman H. Dual role of calmodulin in autophosphorylation of multifunctional CaM kinase may underlie decoding of calcium signals. Neuron 1994, 12:943-956.
6. Erickson J.R., Joiner M.L., Guan X., Kutschke W., Yang J., Oddis C.V., et al. A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell 2008, 133:462-474.
7. Erickson J.R., Pereira L., Wang L., Han G., Ferguson A., Dao K., et al. Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation. Nature 2013, 502:372-376.
8. Bers D.M., Grandi E. Calcium/calmodulin-dependent kinase II regulation of cardiac ion channels. J Cardiovasc Pharmacol 2009, 54:180-187.
9. Mustroph J., Maier L.S., Wagner S. CaMKII regulation of cardiac K channels. Front Pharmacol 2014, 5:20.
10. 2+ current facilitation is CaMKII-dependent and has arrhythmogenic consequences. Front Pharmacol 2014, 5:144.
11. Li N., Chiang D.Y., Wang S., Wang Q., Sun L., Voigt N., et al. Ryanodine receptor- mediated calcium leak drives progressive development of an atrial fibrillation substrate in a transgenic mouse model. Circulation 2014, 129:1276-1285.
12. Wagner S., Dybkova N., Rasenack E.C., Jacobshagen C., Fabritz L., Kirchhof P., et al. Ca/calmodulin-dependent protein kinase II regulates cardiac Na channels. J Clin Invest 2006, 116:3127-3138.
13. Kline C.F., Wright P.J., Koval O.M., Zmuda E.J., Johnson B.L., Anderson M.E., et al. betaIV-Spectrin and CaMKII facilitate Kir6.2 regulation in pancreatic beta cells. Proc Natl Acad Sci U S A 2013, 110:17576-17581.
14. Sierra A., Zhu Z., Sapay N., Sharotri V., Kline C.F., Luczak E.D., et al. Regulation of cardiac ATP-sensitive potassium channel surface expression by calcium/calmodulin-dependent protein kinase II. J Biol Chem 2013, 288:1568-1581.
15. Li J., Kline C.F., Hund T.J., Anderson M.E., Mohler P.J. Ankyrin-B regulates Kir6.2 membrane expression and function in heart. J Biol Chem 2010, 285:28723-28730.
16. Sellers Z.M., De Arcangelis V., Xiang Y., Best P.M. Cardiomyocytes with disrupted CFTR function require CaMKII and Ca(2+)-activated Cl(-) channel activity to maintain contraction rate. J Physiol 2010, 588:2417-2429.
17. Duan D.Y., Liu L.L., Bozeat N., Huang Z.M., Xiang S.Y., Wang G.L., et al. Functional role of anion channels in cardiac diseases. Acta Pharmacol Sin 2005, 26:265-278.
18. Anderson M.E. Sticky fingers: CaMKII finds a home on another ion channel. Circ Res 2009, 104:712-714.
19. 2+ channel facilitation mediated by phosphorylation of the beta subunit by CaMKII. Mol Cell 2006, 23:641-650.
20. Koval O.M., Guan X., Wu Y., Joiner M.L., Gao Z., Chen B., et al. CaV1.2 beta-subunit coordinates CaMKII-triggered cardiomyocyte death and afterdepolarizations. Proc Natl Acad Sci U S A 2010, 107:4996-5000.
21. Hund T.J., Koval O.M., Li J., Wright P.J., Qian L., Snyder J.S., et al. A betaIV spectrin/CaMKII signaling complex is essential for membrane excitability in mice. J Clin Invest 2010, 120:3508-3519.
22. Makara M.A., Curran J., Little S., Musa H., Polina I., Smith S.A., et al. Ankyrin-G coordinates intercalated disc signaling platform to regulate cardiac excitability in vivo. Circ Res 2014, 115:929-938.
23. El-Haou S., Balse E., Neyroud N., Dilanian G., Gavillet B., Abriel H., et al. Kv4 potassium channels form a tripartite complex with the anchoring protein SAP97 and CaMKII in cardiac myocytes. Circ Res 2009, 104:758-769.
24. Zhang T., Maier L.S., Dalton N.D., Miyamoto S., Ross J., Bers D.M., et al. The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure. Circ Res 2003, 92:912-919.
25. Backs J., Backs T., Neef S., Kreusser M.M., Lehmann L.H., Patrick D.M., et al. The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload. Proc Natl Acad Sci U S A 2009, 106:2342-2347.
26. 2+/calmodulin-dependent kinase II in the transition from pressure overload- induced cardiac hypertrophy to heart failure in mice. J Clin Invest 2009, 119:1230-1240.
27. Wu Y., Anderson M.E. CaMKII in sinoatrial node physiology and dysfunction. Front Pharmacol 2014, 5:48.
28. Christ T., Rozmaritsa N., Engel A., Berk E., Knaut M., Metzner K., et al. Arrhythmias, elicited by catecholamines and serotonin, vanish in human chronic atrial fibrillation. Proc Natl Acad Sci U S A 2014, 111:11193-11198.
29. Yaniv Y., Maltsev V.A. Numerical Modeling Calcium and CaMKII Effects in the SA Node. Front Pharmacol 2014, 5:58.
30. Santos G.J., Ferreira S.M., Ortis F., Rezende L.F., Li C., Naji A., et al. Metabolic memory of ss-cells controls insulin secretion and is mediated by CaMKII. Mol Metab 2014, 3:484-489.
31. Ozcan L., Cristina de Souza J., Harari A.A., Backs J., Olson E.N., Tabas I. Activation of calcium/calmodulin-dependent protein kinase II in obesity mediates suppression of hepatic insulin signaling. Cell Metab 2013, 18:803-815.
32. Jain S.S., Paglialunga S., Vigna C., Ludzki A., Herbst E.A., Lally J.S., et al. High-fat diet-induced mitochondrial biogenesis is regulated by mitochondrial-derived reactive oxygen species activation of CaMKII. Diabetes 2014, 63:1907-1913.
33. DeGrande S., Nixon D., Koval O., Curran J.W., Wright P., Wang Q., et al. CaMKII inhibition rescues pro-arrhythmic phenotypes in model of human ankyrin-B syndrome. Heart Rhythm 2012, 9:2034-2041.
34. + channel in cardiac disease. Circulation 2012, 126:2084-2094.
35. +/-) mice with catecholaminergic polymorphic ventricular tachycardia. J Mol Cell Cardiol 2011, 50:214-222.
36. Thiel W.H., Chen B., Hund T.J., Koval O.M., Purohit A., Song L.S., et al. Proarrhythmic defects in Timothy syndrome require calmodulin kinase II. Circulation 2008, 118:2225-2234.
37. Pellicena P., Schulman H. CaMKII inhibitors: from research tools to therapeutic agents. Front Pharmacol 2014, 5:21.
38. Toischer K., Hartmann N., Wagner S., Fischer T.H., Herting J., Danner B.C., et al. Role of late sodium current as a potential arrhythmogenic mechanism in the progression of pressure-induced heart disease. J Mol Cell Cardiol 2013, 61:111-122.
39. Undrovinas A.I., Maltsev V.A., Sabbah H.N. Repolarization abnormalities in cardiomyocytes of dogs with chronic heart failure: role of sustained inward current. Cell Mol Life Sci 1999, 55:494-505.
40. Maltsev V.A., Sabbah H.N., Higgins R.S., Silverman N., Lesch M., Novel Undrovinas AI. ultraslow inactivating sodium current in human ventricular cardiomyocytes. Circulation 1998, 98:2545-2552.
41. 2+/calmodulin-dependent protein kinase II in guinea-pig ventricular myocytes. Cardiovasc Res 2010, 85:454-463.
42. 2+/calmodulin-dependent protein kinase II (CaMKII) regulates cardiac sodium channel NaV1.5 gating by multiple phosphorylation sites. J Biol Chem 2012, 287:19856-19869.
43. Marionneau C., Lichti C.F., Lindenbaum P., Charpentier F., Nerbonne J.M., Townsend R.R., et al. Mass spectrometry-based identification of native cardiac Nav1.5 channel alpha subunit phosphorylation sites. J Proteome Res 2012, 11:5994-6007.
44. Antzelevitch C., Nesterenko V., Shryock J.C., Rajamani S., Song Y., Belardinelli L. The role of late INa in development of cardiac arrhythmias. Handb Exp Pharmacol 2014, 221:137-168.
45. Lin X., Liu N., Lu J., Zhang J., Anumonwo J.M., Isom L.L., et al. Subcellular heterogeneity of sodium current properties in adult cardiac ventricular myocytes. Heart Rhythm 2011, 8:1923-1930.
46. Mohler P.J., Rivolta I., Napolitano C., LeMaillet G., Lambert S., Priori S.G., et al. Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes. Proc Natl Acad Sci U S A 2004, 101:17533-17538.
47. Gavillet B., Rougier J.S., Domenighetti A.A., Behar R., Boixel C., Ruchat P., et al. Cardiac sodium channel Nav1.5 is regulated by a multiprotein complex composed of syntrophins and dystrophin. Circ Res 2006, 99:407-414.
48. Shy D., Gillet L., Ogrodnik J., Albesa M., Verkerk A.O., Wolswinkel R., et al. PDZ domain-binding motif regulates cardiomyocyte compartment-specific NaV1.5 channel expression and function. Circulation 2014, 130:147-160.
49. Ueda K., Valdivia C., Medeiros-Domingo A., Tester D.J., Vatta M., Farrugia G., et al. Syntrophin mutation associated with long QT syndrome through activation of the nNOS-SCN5A macromolecular complex. Proc Natl Acad Sci U S A 2008, 105:9355-9360.
50. Greenstein J.L., Foteinou P.T., Hashambhoy-Ramsay Y.L., Winslow R.L. Modeling CaMKII-mediated regulation of l-type Ca(2+) channels and ryanodine receptors in the heart. Front Pharmacol 2014, 5:60.
51. Onal B., Unudurthi S.D., Hund T.J. Modeling CaMKII in cardiac physiology: from molecule to tissue. Front Pharmacol 2014, 5:9.
52. Hund T.J., Rudy Y. Rate dependence and regulation of action potential and calcium transient in a canine cardiac ventricular cell model. Circulation 2004, 110:3168-3174.
53. 2+ handling and interval-force relations: a modelling study. Philos Transact A Math Phys Eng Sci 2006, 364:1107-1133.
54. Christensen M.D., Dun W., Boyden P.A., Anderson M.E., Mohler P.J., Hund T.J. Oxidized calmodulin kinase II regulates conduction following myocardial infarction: a computational analysis. PLoS Comput Biol 2009, 5:e1000583.
55. Hund T.J., Decker K.F., Kanter E., Mohler P.J., Boyden P.A., Schuessler R.B., et al. Role of activated CaMKII in abnormal calcium homeostasis and INa remodeling after myocardial infarction: insights from mathematical modeling. J Mol Cell Cardiol 2008, 45:420-428.
56. 2+ current facilitation: a modeling study. Biophys J 2009, 96:1770-1785.
57. Koivumaki J.T., Korhonen T., Takalo J., Weckstrom M., Tavi P. Regulation of excitation-contraction coupling in mouse cardiac myocytes: integrative analysis with mathematical modelling. BMC Physiol 2009, 9:16.
58. 2+ handling. Biophys J 2010, 99:2038-2047.
59. + loading and CaMKII. J Physiol 2014, 592:1181-1197.
60. Luo M., Guan X., Di L., Kutschke W., Gao Z., Yang J., et al. Diabetes increases mortality after myocardial infarction by oxidizing CaMKII. J Clin Invest 2013, 123:1262-1274.
61. Swaminathan P.D., Purohit A., Soni S., Voigt N., Singh M.V., Glukhov A.V., et al. Oxidized CaMKII causes sinus node dysfunction in mice. J Clin Invest 2011, 121:3277-3288.
62. 2+ in cardiac myocytes. Biophys J 2008, 95:4597-4612.